Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Only logged in customers who have purchased this product may leave a review.
You may also like
New technologies are fundamentally disrupting the business model for consumer products companies around the world. Relationships between manufacturers and retailers – and the consumers they share – are changing, and new business models are emerging. This is a challenge, certainly, but also a tremendous opportunity.
Achieving Profitable Growth in Consumer Products$0.00 Alix Partner
The digital revolution is resulting in deep changes in consumer habits, caused, among other factors, by greater access to information and increasingly developing new technologies. All this invites us to take an in-depth look into the business models currently being used.
Machine Learning, a key component in business model transformation$0.00 Management Solutions
On display in the Berlin Air Show in June 2016 was ‘Thor’ – the small Airbus marvel that is the world’s first aircraft wholly produced by additive manufacturing (AM). Windowless weighing in at just 21 kilos (46 pounds) and less than four meters (13 feet) long, the drone Thor – short for “Test of High-tech Objectives in Reality” – resembles a large, white model airplane.
3D Printing$0.00 Ipsos Business consulting
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?